Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution

Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups

(2016) Pavel Sumazin et al.   HEPATOLOGY

The diagnostic and prognostic value of SALL4 in hepatoblastoma

(2016) Shengmei Zhou et al.   HISTOPATHOLOGY

Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 Studies

(2016) Maciej Murawski et al.   JOURNAL OF CLINICAL ONCOLOGY

Mixed Transitional Liver Cell Tumor in a 23-Year-Old Female: A Case Report

(2016) Audrey E. Ertel et al.   SEMINARS IN ROENTGENOLOGY

Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution

(2015) Shengmei Zhou et al.   HISTOPATHOLOGY

SALL4 Immunoreactivity Predicts Prognosis in Western Hepatocellular Carcinoma Patients but Is a Rare Event

(2014) Ta-Chiang Liu et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The genomic landscape of hepatoblastoma and their progenies with HCC-like features

(2014) Melanie Eichenmüller et al.   JOURNAL OF HEPATOLOGY

Genome-wide analysis of noncoding regulatory mutations in cancer

(2014) Nils Weinhold et al.   NATURE GENETICS

Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma

(2014) Su-xia Han et al.   Journal of Immunology Research

Identification of driver genes in hepatocellular carcinoma by exome sequencing

(2013) Sean P. Cleary et al.   HEPATOLOGY

SALL4 is a marker of the embryonal subtype of hepatoblastoma

(2013) Viviane Gnemmi et al.   HISTOPATHOLOGY

A review of 218 pediatric cases of hepatocellular carcinoma

(2013) Bassan J. Allan et al.   JOURNAL OF PEDIATRIC SURGERY

Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study

(2013) József Zsiros et al.   LANCET ONCOLOGY

Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma

(2013) Kol Jia Yong et al.   NEW ENGLAND JOURNAL OF MEDICINE

TERT Promoter Mutations in Familial and Sporadic Melanoma

(2013) S. Horn et al.   SCIENCE

Highly Recurrent TERT Promoter Mutations in Human Melanoma

(2013) F. W. Huang et al.   SCIENCE

Mixed Hepatocellular Carcinoma and Hepatoblastoma: Cytohistopathologic Findings and Differential Diagnosis

(2012) Sule Canberk et al.   ACTA CYTOLOGICA

Effects of Neoadjuvant Chemotherapy on Hepatoblastoma: A Morphologic and Immunohistochemical Study

(2010) Larry L. Wang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Pathology of pediatric liver tumors, a single center experience from south of Iran

(2010) Bita Geramizadeh et al.   Indian Journal of Pathology and Microbiology

Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study

(2010) József Zsíros et al.   JOURNAL OF CLINICAL ONCOLOGY

Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma

(2009) Giorgio Perilongo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases

(2007) Debra L. Zynger et al.   HUMAN PATHOLOGY